Equities

Scancell Holdings PLC

SCLP:LSE

Scancell Holdings PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)14.50
  • Today's Change-0.50 / -3.33%
  • Shares traded343.00k
  • 1 Year change-14.04%
  • Beta1.1223
Data delayed at least 20 minutes, as of Sep 27 2024 16:25 BST.
More ▼

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2024, cash reserves at Scancell Holdings PLC fell by 5.10m. Cash Flow from Financing totalled 10.39m or -- of revenues. In addition the company used 15.66m for operations while cash from investing totalled 178.00k.
Cash flow per share-0.0057
Price/Cash flow per share--
Book value per share-0.0038
Tangible book value per share-0.0038
More ▼

Balance sheet in GBPView more

Scancell Holdings PLC has a Debt to Total Capital ratio of 121.42%.
Current ratio3.42
Quick ratio--
Total debt/total equity--
Total debt/total capital1.21
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.